Key Insights

Highlights

Success Rate

82% trial completion

Published Results

29 trials with published results (18%)

Research Maturity

89 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.7%

19 terminated out of 163 trials

Success Rate

82.4%

-4.1% vs benchmark

Late-Stage Pipeline

8%

13 trials in Phase 3/4

Results Transparency

33%

29 of 89 completed with results

Key Signals

29 with results82% success19 terminated

Data Visualizations

Phase Distribution

106Total
Not Applicable (48)
Early P 1 (2)
P 1 (17)
P 2 (26)
P 3 (7)
P 4 (6)

Trial Status

Completed89
Unknown39
Terminated19
Withdrawn9
Not Yet Recruiting4
Recruiting3

Trial Success Rate

82.4%

Benchmark: 86.5%

Based on 89 completed trials

Clinical Trials (163)

Showing 20 of 20 trials
NCT07156669Not Yet Recruiting

Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

NCT00963066Not ApplicableCompletedPrimary

NAV-ALI: Neurally Adjusted Ventilatory Assist in Patients Recovering Spontaneous Breathing After Acute Lung Injury

NCT07499154Phase 4Not Yet Recruiting

Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery

NCT07477951Not ApplicableNot Yet RecruitingPrimary

The Impact of Automatic Lung Recruitment Postoperative Pulmonary Complications

NCT04935697Not ApplicableCompleted

Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress

NCT06750536Recruiting

Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

NCT01089400Completed

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage

NCT06513949Phase 2Recruiting

Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

NCT04693403Not ApplicableCompleted

The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) Study

NCT05704166Phase 2RecruitingPrimary

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

NCT03764319Not ApplicableCompleted

Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO

NCT01304654CompletedPrimary

ALI (Acute Lung Injury) /ARDS (Acute Respiratory Distress Syndrome) in Oncologic Pediatric Patients

NCT04871893Not ApplicableCompletedPrimary

Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy

NCT00742482Phase 3TerminatedPrimary

Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

NCT05316727CompletedPrimary

Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury

NCT01438853Phase 1Completed

Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome

NCT05886998Phase 3Completed

Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury

NCT03937947Completed

Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study

NCT06248320Not ApplicableCompleted

Sigh Ventilation on Postoperative Hypoxemia in Cardiac Surgery

NCT05289570Phase 2TerminatedPrimary

Voxelotor for Improving Oxygen Saturation in Adults

Scroll to load more

Research Network

Activity Timeline